Jeevan Kumar

Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.

Suresh R. Giri, Mukul R Jain, Sameer Agarwal, 2018, Bioorganic & medicinal chemistry letters.

Discovery of diaminopyrimidine-carboxamide derivatives as JAK3 inhibitors.

D. Bandyopadhyay, H. Patel, R. Bahekar, 2020, Bioorganic chemistry.

Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones based novel, potent and PI3Kδ selective inhibitors.

D. Bandyopadhyay, R. Bahekar, Dipam N Patel, 2019, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationship of potent, selective and orally active anthranilamide-based factor Xa inhibitors: application of weakly basic sulfoximine group as novel S4 binding element.

Jigar S. Patel, Bhavesh Parmar, Nirav Joshi, 2012, European journal of medicinal chemistry.

Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.

D. Bandyopadhyay, H. Patel, Suresh R. Giri, 2021, Bioorganic & medicinal chemistry.

Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitor.

D. Bandyopadhyay, Mukul R Jain, P. Giri, 2022, Bioorganic & Medicinal Chemistry Letters.

Novel 2-mercapto imidazole and triazole derivatives as potent TGR5 receptor agonists

Mukul R Jain, Sameer Agarwal, S. Soman, 2019, Medicine in Drug Discovery.

Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitors.

D. Bandyopadhyay, Mukul R Jain, P. Jadav, 2022, Bioorganic chemistry.